NCT01310244 2020-01-06
MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC
Acrotech Biopharma Inc.
Phase 1/2 Completed
Acrotech Biopharma Inc.
National Cancer Institute (NCI)
Valerio Therapeutics
Valerio Therapeutics